We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Flutiform NDA Needs More Data, FDA Tells SkyePharma
Flutiform NDA Needs More Data, FDA Tells SkyePharma
January 29, 2010
The FDA may require SkyePharma to conduct more trials on its asthma drug Flutiform, which may delay its approval.